site stats

Biochemics sec

Web•the SEC served deposition subpoenas on Masiz and two other individuals in January 2012 (during the policy period); • the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and • the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December … WebJan 6, 2015 · Plaintiffs BioChemics, Inc., and John Masiz sued defendant Axis Reinsurance Company (“AXIS”) for defense costs arising out of a Securities and Exchange Commission (“SEC”) investigation and enforcement action under their directors and officers (“D & O”) liability insurance policy.

First Circuit Holds That Subpoena and Subsequent SEC …

WebAug 22, 2024 · According to the SEC complaint, BioChemics, Masiz and co-conspirators were accused of engaging in a fraudulent scheme to sell company securities to approximately 70 investors. The scheme, which ran from 2009 until the middle of 2012, netted at least $9 million. Investors caught up in the scheme resided in 19 different states. Webbiochemistry: [noun] chemistry that deals with the chemical compounds and processes occurring in organisms. dade city government building https://qtproductsdirect.com

Sec. & Exch. Comm

WebMay 23, 2024 · Plaintiffs sought damages for what they claimed was AXIS's breach, under the relevant policy, of its duty to defend them in connection with an investigation conducted by the Securities and Exchange Commission against BioChemics and its officers. WebDeveloper of transdermal drug delivery technology designed to offer treatment for the skin. Webthe SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December 2012 (after the expiration of the policy period). Biochemics notified AXIS of the January and March 2012 subpoenas. dade city golf courses

Biochemics, Inc. v. Axis Reinsurance Co., 963 F. Supp. 2d 64

Category:BioChemics Claims It Can Pay Chunk Of $17M SEC Judgment

Tags:Biochemics sec

Biochemics sec

Sec. & Exch. Comm

WebBiochemists work in industries like agriculture, medical research, biotechnology and nutritional research. Our students go on to positions in research and industry, as well as graduate study in biochemistry, … WebAug 7, 2013 · BioChemics is a specialty pharmaceutical company focused on transdermal drug delivery systems, including medicated lotions. Masiz is BioChemics's president and chief executive officer. In May 2011 and September 2011, the SEC served document subpoenas on BioChemics requesting a broad range of documents regarding the …

Biochemics sec

Did you know?

WebDec 16, 2012 · Three repeat securities law violators teamed up to defraud 70 investors of over $9 million over three years. The complaint claims the defendants sold interests in a privately held biochemical company based on a series of misrepresentations. SEC v. Biochemics, Inc., Civil Action No. 1:12-cv-12324 (D. Mass. Filed Dec. 14, 2012).

WebFeb 3, 2015 · § the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and § the SEC filed an enforcement action against Biochemics, Masiz, and two promoters... WebThe SEC claimed in a 2012 lawsuit that BioChemics and Masiz lied about the status of topical gels that would allow medicine to be absorbed through the skin. They allegedly falsely asserted the...

WebSep 6, 2024 · In Biochemics, Inc. v. AXIS Reinsurance Company, 2024 WL 2223125 (1st Cir. 2024), the SEC issued a subpoena to Biochemics on May 5, 2011, requesting that Biochemics produce certain documentation in connection with the SEC’s investigation into whether Biochemics and its President and CEO, John Masiz, had committed securities … WebThe treatment that could produce the money for BioChemics to pay down its SEC debt is already being prescribed by doctors associated with “leading medical institutions,” Schlichtmann said. In addition to the $17.2 million BioChemics owes the SEC, Florida-based private equity firm ADEC Private

WebGet free access to the complete judgment in Sec. & Exch. Comm'n v. BioChemics, Inc. on CaseMine.

WebMar 25, 2015 · The judgment entered on March 25, 2015, supplements the March 18, 2015 judgment, and requires BioChemics to disgorge $15,105,325 in ill-gotten gains plus … dade city home inspectorsWebDec 16, 2012 · The SEC claims that in 2010 and 2011 BioChemics, Masiz, and Kroning misrepresented to investors and potential investors the status of research collaborations with other pharmaceutical companies: “For example, in 2010 and 2011, BioChemics published a multiple-page overview entitled Executive Summary (“Executive Summary”) that touted … bins that work with cash appWebIn 2015, the SEC won a $17.2 million judgment against BioChemics stemming from an allegation that BioChemics misled 70 investors by exaggerating the positive test results … dade city hospital flWebJan 14, 2014 · Biochemics, Inc. Overview. Biochemics, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on Tuesday, January 14, 2014 and is approximately nine years old, as recorded in documents filed with Texas Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state … dade city hospital fax numberWebDec 17, 2012 · Courthouse News Staff / December 17, 2012. BOSTON (CN) - An attorney duped investors for $9 million through his purported biopharma company, Biochemics, … dade city gun shopWebJun 24, 2024 · In BioChemics, Inc. v. AXIS Reinsurance Co., 2024 WL 2223125 (1st Cir. May 23, 2024), the United States Court of Appeals for the First Circuit held that a D&O policy did not provide coverage for an SEC … bin stickers b\\u0026qWebBioChemics paid $750,000 towards the judgment on Oct. 23, 2015. More than two years passed before its next deposit, an $87,500 payment to the SEC on Jan. 16, 2024, and … bins that lock